Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Deficit (Unaudited)

v3.21.2
Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, shares at Dec. 31, 2019 3,932 12      
Beginning balance, value at Dec. 31, 2019 $ 393 $ (1,721) $ 182,514 $ (185,665)
Common stock issued, shares 37        
Common stock issued $ 1      
Restricted stock issued, shares 6        
Restricted stock issued        
Common stock issued through market sales, shares 80        
Common stock issued through market sales $ 8   476    
Common stock issued through ESPP, shares        
Common stock issued through ESPP        
Treasury stock purchased, shares        
Treasury stock purchased        
Extinguishment of Series A Shares     (828)    
Beneficial Conversion Feature in connection with Series B Issuance     2,205    
Amortization of Beneficial Conversion Feature     (2,205)    
Stock-based compensation expense     418  
Net loss       (6,494)  
Ending balance, shares at Mar. 31, 2020 4,055 12      
Ending balance, value at Mar. 31, 2020 $ 402 $ (1,721) 182,580 (192,159)
Beginning balance, shares at Dec. 31, 2019 3,932 12      
Beginning balance, value at Dec. 31, 2019 $ 393 $ (1,721) 182,514 (185,665)
Net loss         (12,074)
Ending balance, shares at Jun. 30, 2020 4,055 19      
Ending balance, value at Jun. 30, 2020 $ 402 $ (1,770) 182,980 (197,739) (16,127)
Beginning balance, shares at Mar. 31, 2020 4,055 12      
Beginning balance, value at Mar. 31, 2020 $ 402 $ (1,721) 182,580 (192,159)
Common stock issued, shares        
Common stock issued        
Treasury stock purchased, shares   7      
Treasury stock purchased   $ (49)      
Stock-based compensation expense     400  
Net loss       (5,580) (5,580)
Ending balance, shares at Jun. 30, 2020 4,055 19      
Ending balance, value at Jun. 30, 2020 $ 402 $ (1,770) 182,980 (197,739) (16,127)
Beginning balance, shares at Dec. 31, 2020 4,075 20      
Beginning balance, value at Dec. 31, 2020 $ 402 $ (1,773) 184,404 (212,116) (29,083)
Common stock issued, shares 9        
Common stock issued   108    
Restricted stock issued, shares 12        
Restricted stock issued        
Common stock issued through market sales, shares        
Common stock issued through market sales      
Common stock issued through ESPP, shares 36        
Common stock issued through ESPP        
Treasury stock purchased, shares        
Treasury stock purchased        
Extinguishment of Series A Shares        
Beneficial Conversion Feature in connection with Series B Issuance        
Amortization of Beneficial Conversion Feature        
Stock-based compensation expense     286  
Net loss       (4,207)  
Ending balance, shares at Mar. 31, 2021 4,132 20      
Ending balance, value at Mar. 31, 2021 $ 402 $ (1,773) 184,798 (216,323)
Beginning balance, shares at Dec. 31, 2020 4,075 20      
Beginning balance, value at Dec. 31, 2020 $ 402 $ (1,773) 184,404 (212,116) (29,083)
Net loss         (7,653)
Ending balance, shares at Jun. 30, 2021 4,142 20      
Ending balance, value at Jun. 30, 2021 $ 402 $ (1,773) 185,349 (219,769) (35,791)
Beginning balance, shares at Mar. 31, 2021 4,132 20      
Beginning balance, value at Mar. 31, 2021 $ 402 $ (1,773) 184,798 (216,323)
Common stock issued, shares 10        
Common stock issued        
Treasury stock purchased, shares        
Treasury stock purchased        
Stock-based compensation expense     551  
Net loss       (3,446) (3,446)
Ending balance, shares at Jun. 30, 2021 4,142 20      
Ending balance, value at Jun. 30, 2021 $ 402 $ (1,773) $ 185,349 $ (219,769) $ (35,791)